Back to top
Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 4th:

Lam Research Corporation (LRCX - Free Report) : This manufacturer of semiconductor processing equipment, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.8% over the last 60 days.

Lam Research Corporation Price and Consensus

Lam Research has a PEG ratio of 0.86, compared with 1.13 for the industry. The company possesses a Growth Score of A.

Lam Research Corporation PEG Ratio (TTM)

Chemours Company (CC - Free Report) : This provider of performance chemicals, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 2.8% over the last 60 days.

Chemours Company (The) Price and Consensus

Chemours Company has a PEG ratio of 0.90, compared with 1.89 for the industry. The company possesses a Growth Score of A.

Chemours Company (The) PEG Ratio (TTM)

Statoil ASA (STO - Free Report) : This energy company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.

Statoil ASA Price and Consensus

Statoil has a PEG ratio of 0.64, compared with 2.52 for the industry. The company possesses a Growth Score of A.

Statoil ASA PEG Ratio (TTM)

Burlington Stores, Inc. (BURL - Free Report) : This retailer of branded apparel products, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.

Burlington Stores, Inc. Price and Consensus

Burlington Stores has a PEG ratio of 1.46, compared with 1.59 for the industry. The company possesses a Growth Score of A.

Burlington Stores, Inc. PEG Ratio (TTM)

See the full list of top ranked stocks here                                  

Learn more about the Growth score and how it is calculated here.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



More from Zacks Zacks #1 Rank Additions

You May Like